|
Q4 FY2026
As of Feb 28, 2026
|
Q4 FY2025
As of Feb 28, 2025
|
Q4 FY2024
As of Feb 29, 2024
|
Q4 FY2023
As of Feb 28, 2023
|
Q4 FY2022
As of Feb 28, 2022
|
Q4 FY2021
As of Feb 28, 2021
|
Q4 FY2020
As of Feb 29, 2020
|
Q4 FY2019
As of Feb 28, 2019
|
Q4 FY2018
As of Feb 28, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current assets | |||||||||
| Cash and cash equivalents | |||||||||
| Restricted cash, current | |||||||||
| Accounts receivable, net of allowance for credit losses of nil and nil as of February 28, 2025 and 2026, respectively | |||||||||
| Other receivables, deposits and other assets, net of allowance for credit losses of RMB3,652 and RMB3,784 as of February 28, 2025 and 2026, respectively | |||||||||
| Amounts due from related parties, net | |||||||||
| Short-term investments | |||||||||
| Short-term investments under fair value | |||||||||
| Long-term investments under fair value, current | |||||||||
| Total current assets | |||||||||
| Non-current assets | |||||||||
| Restricted cash, non-current | |||||||||
| Property and equipment, net | |||||||||
| Operating lease right-of-use assets | |||||||||
| Intangible assets, net | |||||||||
| Goodwill | |||||||||
| Long-term investments, net | |||||||||
| Long-term investments under fair value, non-current | |||||||||
| Other non-current assets | |||||||||
| Total non-current assets | |||||||||
| TOTAL ASSETS | |||||||||
| Liabilities | |||||||||
| Current liabilities | |||||||||
| Accounts payable | |||||||||
| Amounts due to related parties | |||||||||
| Accrued expenses and other current liabilities | |||||||||
| Operating lease liabilities, current | |||||||||
| Income tax payable | |||||||||
| Deferred revenue | |||||||||
| Long-term borrowings, current | |||||||||
| Total current liabilities | |||||||||
| Non-current liabilities | |||||||||
| Long-term borrowings | |||||||||
| Operating lease liabilities, non-current | |||||||||
| Total non-current liabilities | |||||||||
| TOTAL LIABILITIES | |||||||||
| EQUITY | |||||||||
| Ordinary shares (US$0.0001 par value; 500,000,000 shares authorized, 22,600,576 and 22,614,376 shares issued and outstanding as of February 28, 2025 and 2026, respectively) | |||||||||
| Additional paid-in capital | |||||||||
| Treasury shares (2,363,567 and 2,363,567 shares as of February 28, 2025 and 2026, respectively) | |||||||||
| Accumulated deficit | |||||||||
| Accumulated other comprehensive income | |||||||||
| Shareholders’ equity | |||||||||
| Non-controlling interests | |||||||||
| Total equity | |||||||||
| TOTAL LIABILITIES AND EQUITY | |||||||||
Loading...
